Mirae Asset Global Investments’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
Other funds holding COGT
EA
EMFAT
Mirae Asset Global Investments's COGT Position: Q2 2026 in Review
Mirae Asset Global Investments reduced its Cogent Biosciences (COGT) stake by 9.7% in Q2 2026, selling an estimated $28.8K and leaving 7,642 shares worth $296K. The position accounts for ﹤0.01% of the portfolio, ranked #1065.
Mirae Asset Global Investments first reported a position in COGT in Q2 2022 and has held it in 17 quarters since. The position peaked at $446K in Q1 2024. 96 funds tracked by Wall St. Rank hold COGT as of Q2 2026.
- Mirae Asset Global Investments held 7,642 shares of Cogent Biosciences worth $296K as of Q2 2026.
- Mirae Asset Global Investments sold 824 Cogent Biosciences shares in Q2 2026, an estimated $28.8K.
- Cogent Biosciences made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1065 holding.
- Mirae Asset Global Investments first reported a position in Cogent Biosciences in Q2 2022 and has held it in 17 quarters since.
- Mirae Asset Global Investments's Cogent Biosciences position peaked at $446K in Q1 2024.
- 96 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.
Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.